158 related articles for article (PubMed ID: 8483079)
21. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Takeda T; Shimada M; Iizuka S; Takasugi N
Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
[TBL] [Abstract][Full Text] [Related]
22. Results of mass screening for neuroblastoma in Sapporo, Japan.
Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
[No Abstract] [Full Text] [Related]
23. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
24. A pilot study of screening for neuroblastoma in the north of England.
Craft AW; Parker L; Dale G; McGill AC; Seviour JA; Bell S; Cole M; Smith J
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):337-41. PubMed ID: 1456400
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
Scriver CR; Gregory D; Bernstein M; Clow CL; Weisdorf T; Dougherty GE; Auray-Blais C; Giguère R; Lemieux B; Laberge C
CMAJ; 1987 May; 136(9):952-6. PubMed ID: 3105859
[TBL] [Abstract][Full Text] [Related]
26. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
Woods WG; Tuchman M; Lemieux B
Prog Clin Biol Res; 1991; 366():585-94. PubMed ID: 2068177
[No Abstract] [Full Text] [Related]
27. Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions.
Mahoney NR; Liu GT; Menacker SJ; Wilson MC; Hogarty MD; Maris JM
Am J Ophthalmol; 2006 Oct; 142(4):651-9. PubMed ID: 17011859
[TBL] [Abstract][Full Text] [Related]
28. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
[TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
[TBL] [Abstract][Full Text] [Related]
30. Mass screening of neuroblastoma in Sapporo City, Japan.
Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
[TBL] [Abstract][Full Text] [Related]
31. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
32. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
[TBL] [Abstract][Full Text] [Related]
33. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
[TBL] [Abstract][Full Text] [Related]
34. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
Nishi M; Miyake H; Takeda T; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hirama T; Ishikawa Y; Kudoh T; Azuma H; Takase A
Oncol Rep; 1998; 5(3):631-3. PubMed ID: 9538165
[TBL] [Abstract][Full Text] [Related]
35. Cystic neuroblastoma.
Croitoru DP; Sinsky AB; Laberge JM
J Pediatr Surg; 1992 Oct; 27(10):1320-1. PubMed ID: 1403512
[TBL] [Abstract][Full Text] [Related]
36. Problems of mass screening for neuroblastoma: analysis of false-negative cases.
Ishimoto K; Kiyokawa N; Fujita H; Yabuta K; Ohya T; Miyano T; Shinohara T; Sera Y
J Pediatr Surg; 1990 Apr; 25(4):398-401. PubMed ID: 2329455
[TBL] [Abstract][Full Text] [Related]
37. Screening infants for neuroblastoma: discovery of alkaptonuria in one case.
Mathieu P; Prevel A; David L; Bergeron C; Bory C; Chauvin F; Dia S; Frappaz D; Greffe J; Mathieu M; Philip T
Clin Chim Acta; 1997 Aug; 264(2):255-9. PubMed ID: 9293385
[No Abstract] [Full Text] [Related]
38. Mass screening for neuroblastoma in Japan.
Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
[TBL] [Abstract][Full Text] [Related]
39. Can a patient with neuroblastoma be diagnosed by a single urine sample collected randomly?
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Oncology; 1991; 48(1):31-3. PubMed ID: 1987496
[TBL] [Abstract][Full Text] [Related]
40. Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma.
Monsaingeon M; Perel Y; Simonnet G; Corcuff JB
Eur J Pediatr; 2003 Jun; 162(6):397-402. PubMed ID: 12684897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]